{"organizations": [], "uuid": "0c8deba943cf3a81523fbc1e05d592b1df46b3db", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/29/pr-newswire-shareholder-alert-purcell-julie-lefkowitz-llp-is-investigating-aevi-genomic-medicine-inc-for-potential-breaches-of-fiduciary.html", "country": "US", "domain_rank": 767, "title": "SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.993, "site_type": "news", "published": "2018-04-30T02:56:00.000+03:00", "replies_count": 0, "uuid": "0c8deba943cf3a81523fbc1e05d592b1df46b3db"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/29/pr-newswire-shareholder-alert-purcell-julie-lefkowitz-llp-is-investigating-aevi-genomic-medicine-inc-for-potential-breaches-of-fiduciary.html", "ord_in_thread": 0, "title": "SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors", "locations": [], "entities": {"persons": [{"name": "robert h. lefkowitz", "sentiment": "none"}], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "esq.", "sentiment": "none"}], "organizations": [{"name": "purcell julie & lefkowitz llp", "sentiment": "neutral"}, {"name": "aevi genomic medicine, inc.", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEW YORK, April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX).\nIf you are a shareholder of Aevi Genomic Medicine, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at:\nhttp://pjlfirm.com/aevi-genomic-medicine-inc/\nYou may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000. One of our attorneys will personally speak with you about the case at no cost or obligation.\nPurcell Julie & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit http://pjlfirm.com . Attorney advertising. Prior results do not guarantee a similar outcome.\nView original content: http://www.prnewswire.com/news-releases/shareholder-alert-purcell-julie--lefkowitz-llp-is-investigating-aevi-genomic-medicine-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors-300638646.html\nSOURCE Purcell Julie & Lefkowitz LLP", "external_links": ["http://pjlfirm.com/aevi-genomic-medicine-inc/", "http://www.prnewswire.com/news-releases/shareholder-alert-purcell-julie--lefkowitz-llp-is-investigating-aevi-genomic-medicine-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors-300638646.html"], "published": "2018-04-30T02:56:00.000+03:00", "crawled": "2018-04-30T04:02:35.018+03:00", "highlightTitle": ""}